Informa Pharma Intelligence releases Citeline's next generations of Sitetrove, Trialtrove and new API solutions
(Thomson Reuters ONE) -
The industry's most comprehensive clinical trial data and analysis, now
delivered to better fit customers' individual needs and workflows
Summary: Informa Pharma Intelligence announces three major releases for its
clinical R&D Intelligence suite. The same leading global intelligence trusted by
thousands worldwide for over 35 years is now backed by even more powerful,
cutting edge technology. These new solutions will allow users to go deeper with
clinical trial research than ever before, and will offer new options to help
users better integrate Citeline's leading content with their own data.
LONDON, June 19, 2017 (GLOBE NEWSWIRE) -- Informa Pharma Intelligence, the
leading provider of drug, device, company, clinical trial, and market
intelligence in the competitive pharma and medtech markets announces today the
launch of its next generation of Citeline's Sitetrove and Trialtrove solutions,
as well as new application programming interfaces (APIs) for Trials and Drugs.
The new solutions are designed to deliver unparalleled access to Citeline's
robust clinical trial intelligence with greater ease, speed and efficiency than
ever before.
"Our next generation of clinical R&D Intelligence solutions are truly market
driven," said Linda Blackerby, President of Informa Pharma Intelligence. "We
have partnered with hundreds of customers to understand their data needs and
workflows, and have developed our new Citeline platform and APIs based directly
on their feedback."
The new Trialtrove and Sitetrove provides users with the ability to go even
deeper with search criteria to make better and more well-informed critical
decisions, gain competitive advantage, save costs on and optimize ROI for their
clinical trials. The new APIs will also come with Informa's acclaimed Ask-the-
Analyst service, connecting users with therapeutic expert analysts whose average
response time to queries is 24 hours or less.
Informa's new Trials and Drugs APIs will enable users to search or stream
information directly from Citeline's R&D Intelligence databases into their own
systems and embed Informa's quality datasets directly into their own
organization's data and workflows, minimizing duplicated effort and time spent
acquiring and manipulating data.
"Clinical R&D professionals need to design strategies, develop protocols, plan
and execute trials that are on budget and on time," said Nicola Marlin, Vice
President of Product. "Our team of scientific analysts live and breathe the data
universe to bring our customers a deep understanding of the current clinical
trial landscape. The new Citeline platform and API solutions allow users to
enjoy the same depth and breadth of specialized, high caliber content, delivered
the way they want to better fit their need, internal solutions, and workflows."
"These new releases further reinforce our commitment to our customers to help
them gain critical insights into the global clinical trial landscape, realize
greater cost-savings and ROI as they develop on their clinical trial programs,"
stated Michael Hay, Head of Intelligence. "No other intelligence solution comes
close."
Attendees at this week's DIA and BIO International conferences will get a sneak
preview of these next generation solutions, which will begin launching to
customers in July. Additional solutions including the next generation of
Citeline's Pharmaprojects and additional APIs for Investigators and Sites are in
development for launch later this year.
For more information, visit pharmaintelligence.informa.com.
About Informa Pharma Intelligence
Informa Pharma Intelligence powers a full suite of analysis products -
Datamonitor Healthcare, Sitetrove, Trialtrove, Pharmaprojects, Medtrack,
Biomedtracker, Scrip, Pink Sheet and In Vivo - to deliver the data needed by the
pharmaceutical and biomedical industry to make decisions and create real-world
opportunities for growth.
With more than 500 analysts keeping their fingers on the pulse of the industry,
no key disease, clinical trial, drug approval or R&D project isn't covered
through the breadth and depth of data available to customers. For more
information visit pharmaintelligence.informa.com.
About Citeline
Citeline, part of Informa's Pharma Intelligence vertical, is the world's most
comprehensive source of real-time R&D intelligence for the pharmaceutical
industry, featuring an unmatched intelligence collection and enrichment of
global clinical trials, clinical trial investigator profiles and drug
development pipelines.
Citeline is the R&D Intelligence arm of Informa's Pharma Intelligence vertical,
one of the world's leading providers of drug, device, company, clinical trial
and market intelligence in the pharma and medtech markets. For more
information, visit pharmaintelligence.informa.com.
Michael Hay
T: (212) 652-5302
Michael.hay(at)informa.com
This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Informa Business Intelligence via GlobeNewswire
Datum: 19.06.2017 - 17:29 Uhr
Sprache: Deutsch
News-ID 548658
Anzahl Zeichen: 5837
contact information:
Town:
New York
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 352 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Informa Pharma Intelligence releases Citeline's next generations of Sitetrove, Trialtrove and new API solutions"
steht unter der journalistisch-redaktionellen Verantwortung von
Informa Business Intelligence (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
